Autophagy triggered by magnolol derivative negatively regulates angiogenesis

Author(s): Kumar S, Guru SK, Pathania AS, Kumar A, Bhushan S, et al.


Angiogenesis has a key role in the tumor progression and metastasis; targeting endothelial cell proliferation has emerged as a promising therapeutic strategy for the prevention of cancer. Previous studies have revealed a complex association between the process of angiogenesis and autophagy and its outcome on tumorigenesis. Autophagy, also known as type-II cell death, has been identified as an alternative way of cell killing in apoptotic-resistant cancer cells. However, its involvement in chemoresistance and tumor promotion is also well known. In this study, we used a derivate of natural product magnolol (Ery5), a potent autophagy inducer, to study the association between the autophagy and angiogenesis in both in vitro and in vivo model system. We found that the robust autophagy triggered by Ery5, inhibited angiogenesis and caused cell death independent of the apoptosis in human umbilical cord vein endothelial cells and PC-3 cells. Ery5 induced autophagy effectively inhibited cell proliferation, migration, invasion and tube formation. We further demonstrated that Ery5-mediated autophagy and subsequent inhibition of angiogenesis was reversed when autophagy was inhibited through 3-methyl adenine and knocking down of key autophagy proteins ATG7 and microtubule-associated protein light chain 3. While evaluating the negative regulation of autophagy on angiogenesis, it was interesting to find that angiogenic environment produced by the treatment of VEGF and CoCl2 remarkably downregulated the autophagy and autophagic cell death induced by Ery5. These studies, while disclosing the vital role of autophagy in the regulation of angiogenesis, also suggest that the potent modulators of autophagy can lead to the development of effective therapeutics in apoptosis-resistant cancer.

Similar Articles

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene

Author(s): Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, et al.

Defective autophagy leads to cancer

Author(s): Edinger AL, Thompson CB

Induction of autophagy and inhibition of tumorigenesis by beclin 1

Author(s): Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, et al.

Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours

Author(s): Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, et al.

Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma

Author(s): Daniel F, Legrand A, Pessayre D, Borrega-Pires F, Mbida L, et al.

Beclin 1 gene inhibits tumor growth in colon cancer cell lines

Author(s): Koneri K, Goi T, Hirono Y, Katayama K, Yamaguchi A

Role of autophagy in cancer

Author(s): Mathew R, Karantza-Wadsworth V, White E

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

Author(s): Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, et al.

Autophagy is a therapeutic target in anticancer drug resistance

Author(s): Chen S, Rehman SK, Zhang W, Wen A, Yao L, et al.

Tissue transglutaminase inhibits autophagy in pancreatic cancer cells

Author(s): Akar U, Ozpolat B, Mehta K, Fok J, Kondo Y, et al.

Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes

Author(s): Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, et al.

Hallmarks of cancer: the next generation

Author(s): Hanahan D, Weinberg RA

Pancreatic cancer biology and genetics

Author(s): Bardeesy N, DePinho RA

Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

Author(s): Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, et al.

The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells

Author(s): Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, et al.